CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
XprESS Multi-Sinus Dilation Tooldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01612780
NCT01612780N/ACompleted
CompareCT.gov

Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study

Entellus Medical, Inc.·interventional·Posted Jun 6, 2012·Updated Oct 22, 2020

In Brief

A clinical study evaluating XprESS Multi-Sinus Dilation Tool for Sinusitis. Completed, enrolled 82 participants across 1 site.

Detailed Summary

The purpose of this study is to show clinically meaningful improvement in symptom severity after transnasal balloon dilation of the maxillary sinus outflow tract with or without balloon dilation of the frontal or sphenoid sinuses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSinusitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 6, 2012
Enrollment StartApr 1, 2012
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.1 years ago

Interventions

XprESS Multi-Sinus Dilation Tooldevice

Sinus balloon dilation